Amoy Diagnostics Co Ltd - Company Profile
Powered by
All the data and insights you need on Amoy Diagnostics Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Amoy Diagnostics Co Ltd Strategy Report
- Understand Amoy Diagnostics Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Amoy Diagnostics Co Ltd (AmoyDx) is a pharmaceutical company that develops molecular diagnostics for oncology precision medicine. The company's product portfolio comprises single-gene testing kits, multi-gene testing panels, NGS panels and NGS analytical systems among others. It serves the domestic and international oncology sectors. AmoyDx partners with AstraZeneca, Johnson & Johnson, Amgen, Eli Lilly, Merck, Eisai, Hengrui and BeiGene for trials of drugs in clinical development and for clinical practice. The company markets its products through a network of distributors in Taiwan, Hong Kong, Bangkok, the Philippines and Malaysia among others. AmoyDx is headquartered in Xiamen, Fujian, China.
Amoy Diagnostics Co Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Diagnostic Assays | ADx-ARMS |
Single-Gene Testing Kits | Super-ARMS |
NGS Analytical Systems | ddCapture |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In November, the company entered into multiple collaborations with AstraZeneca and Pfizer to promote the development of precision diagnostics and treatment benefiting cancer patients. |
2023 | Contracts/Agreements | In July, the company entered into a collaboration with Astrazeneca for HRD companion Diagnostic. |
2023 | Regulatory Approval | In April, the company received approval from the Ministry of Health, Labor and Welfare of Japan for a polymerase chain reaction-based pan-lung cancer (PLC) panel. |
Competitor Comparison
Key Parameters | Amoy Diagnostics Co Ltd | Shanghai Kehua Bio-engineering Co Ltd | Guangzhou Wondfo Biotech Co Ltd | Beijing Strong Biotechnologies Inc | Dirui Industrial Co Ltd |
---|---|---|---|---|---|
Headquarters | China | China | China | China | China |
City | Xiamen | Shanghai | Guangzhou | Beijing | Changchun |
State/Province | Fujian | Shanghai | Guangdong | Beijing | Jilin |
No. of Employees | 1,101 | 2,709 | 3,459 | 1,094 | 1,879 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Li-Mou Zheng | Chairman | Executive Board | 2015 | 70 |
Ruan Li | Deputy General Manager; Director | Executive Board | 2015 | 45 |
Frank Ron Zheng | Director; Deputy General Manager | Executive Board | 2021 | 33 |
Luo Jimin | General Manager - Rotating; Director | Executive Board | - | - |
Chen Ying | Secretary; Chief Financial Officer | Senior Management | 2015 | 53 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward